title: Omit HLA matching to attain shorter cold ischemic time?
authors.affiliation: National Institute of Transplantation, USC School of Medicine, Los Angeles 90057.
authors.forename: S
authors.initials: S
authors.lastname: Aswad
authors.forename: S L
authors.initials: SL
authors.lastname: Mann
authors.forename: U
authors.initials: U
authors.lastname: Khetan
authors.forename: P
authors.initials: P
authors.lastname: Asai
authors.forename: T
authors.initials: T
authors.lastname: Bogaard
authors.forename: R G
authors.initials: RG
authors.lastname: Mendez
authors.forename: R
authors.initials: R
authors.lastname: Mendez
mesh_terms: D000293:Adolescent; D000328:Adult; D002102:Cadaver; D002648:Child; D003080:Cold Temperature; D005260:Female; D006085:Graft Survival / Q000276:immunology / Q000502:physiology*; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007511:Ischemia; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009926:Organ Preservation; D012189:Retrospective Studies; D013997:Time Factors; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000458:organization & administration*
chemical_list: D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens